Evidence map›Paper›PMID 32040553›Full record

SynthesisBlood advances2020

Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis.

Rasha Khatib, Stephanie Ross, Sean Alexander Kennedy, Ivan D Florez, Thomas L Ortel, Robby Nieuwlaat, Ignacio Neumann, Daniel M Witt, Sam Schulman, Veena Manja and 5 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Blood advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. JTH in Clinic: management of low-risk pulmonary embolism.Journal of thrombosis and haemostasis : JTH · 2024
    Review
  5. Article
  6. Implementation Science Opportunities in Cardiovascular Medicine.Circulation. Cardiovascular quality and outcomes · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rasha KhatibAdvocate Research Institute, Advocate Health Care, Downers Grove, IL.
Stephanie RossDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Sean Alexander KennedyDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Ivan D FlorezDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Thomas L OrtelDivision of Hematology, Medicine and Pathology, Duke University Medical Center, Durham, NC.
Robby NieuwlaatDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Ignacio NeumannDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Daniel M WittDepartment of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT.
Sam SchulmanDepartment of Medicine, McMaster University, Hamilton, ON, Canada.
Veena ManjaDepartment of Surgery, University of California Davis, Sacramento, CA.
Rebecca BeythDivision of General Internal Medicine, Department of Medicine, University of Florida, Gainesville, FL.
Nathan P ClarkClinical Pharmacy Anticoagulation Service, Kaiser Permanente Colorado, Aurora, CO; and.
Wojtek WierciochDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Holger J SchünemannDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Yuqing ZhangDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence supports the safety and effectiveness of managing low-risk deep vein thrombosis (DVT) or pulmonary embolism (PE) in outpatient settings. We performed a systematic review to assess safety and effectiveness of managing patients with DVT or PE at home compared with the hospital. Medline, Embase, and Cochrane databases were searched up to July 2019 for relevant randomized clinical trials (RCTs), and prospective cohort studies. Two investigators independently screened titles and abstracts of identified citations and extracted data from relevant full-text papers. Risk ratios (RRs) were calculated, and certainty of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE). Seven RCTs (1922 patients) were included in meta-analyses on managing patients with DVT. Pooled estimates indicated decreased risk of PE (RR = 0.64; 95% confidence interval [CI], 0.44-0.93) and recurrent DVT (RR = 0.61; 95% CI, 0.42-0.90) for home management, both with moderate certainty of the evidence. Reductions in mortality and major bleeding were not significant, both with low certainty of the evidence. Two RCTs (445 patients) were included in meta-analyses on home management of low-risk patients with PE. Pooled estimates indicated no significant difference in all-cause mortality, recurrent PE, and major bleeding, all with low certainty of the evidence. Results of pooled estimates from 3 prospective cohort studies (234 patients) on home management of PE showed similar results. Our findings indicate that low-risk DVT patients had similar or lower risk of patient-important outcomes with home treatment compared with hospital treatment. In patients with low-risk PE, there was important uncertainty about a difference between home and hospital treatment.

Indexed as

Pulmonary EmbolismVenous ThromboembolismVenous ThrombosisAnticoagulantsHospitalsHumansAnticoagulants

Identifiers

PMID32040553
PMCPMC7013254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.